Bausch Health Companies | VRX - Betriebsergebnis

Aktienkurs
7.00
Täglich Wechseln
-0.12 -1.62%
Monatlich
-13.75%
Jährlich
-30.26%
Q1 Prognose
6.65




Betriebsergebnis Veränderung Datum
Amgen USD 3.96B 464M 2025-12
ANI Pharmaceuticals USD 29.13M 6.3M 2025-12
Aurora Cannabis CAD -55.67M 35.45M 2025-09
Bausch Health Companies USD 719M 2M 2025-12
Biogen USD 659.6M 192.2M 2025-09
Bristol-Myers Squibb USD 4.2B 562M 2025-12
Canopy Growth CAD -14.3M 3.18M 2025-09
Corcept Therapeutics USD 4.49M 5.73M 2025-12
Danaher USD 1.5B 348M 2025-12
Drreddys Laboratories INR 14.33B 2.51B 2025-12
Eli Lilly USD 8.99B 599.9M 2025-12
Gilead Sciences USD 2.96B 551M 2025-12
Nektar Therapeutics USD -34.34M 15.43M 2024-09
Novo Nordisk DKK 32.38B 1.7B 2025-12
Pacira USD 3.19M 9.96M 2025-12
Perrigo USD 84.4M 9M 2025-12
Phibro Animal Health USD 54.99M 2.36M 2025-12
Prestige Brands USD 82.49M 2.82M 2025-12
Supernus Pharmaceuticals USD 13.82M 74.01M 2025-12
Vertex Pharmaceuticals USD 1.26B 24.5M 2025-12
Zoetis USD 835M 101M 2025-12